ARCHIVES

Changes Put Pharma In Control Of Trials Traditionally Conducted By Academics.

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

Program Announcement; NCI Seeks Studies Of Breast Cancer In Northeast U.S.

January 22, 1993

Sorafenib Targets AML Driven By Mutant FLT3 Gene

February 29, 2008

“Perhaps the most troubling finding was a broad dissatisfaction with the general ethos within the intramural community.”

July 14, 1995

Bennett, Turner & Coleman Law Firm To Merge With Ropes & Gray

July 5, 2002

NCI High School Summer Program Called Successful

October 19, 1990

Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering

September 3, 2010